| Dr Meghan Gunn, MD | |
|
140 Hospital Dr Ste 210, Bennington, VT 05201-5015 | |
| (802) 447-3930 | |
| Not Available |
| Full Name | Dr Meghan Gunn |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 140 Hospital Dr Ste 210, Bennington, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811216815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 042.0012635 (Vermont) | Primary |
| Entity Name | Southwestern Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184994162 PECOS PAC ID: 0143138446 Enrollment ID: O20120613000217 |
News Archive
Proteins are the workhorses of our cells. They help to digest our food, are at the core of our immune system, and literally shape our body from top to toe. Proteins also play an important role in biotechnology in the form of enzymes, which are important in the creation of anything from pharmaceuticals to bread, washing powder and much more. Their possibilities are virtually without limit.
A clinical trial initiated by University of Kentucky researchers argues against the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass. The double-blind trial, conducted at the University of Kentucky and University of Alabama at Birmingham, found that older adults who took metformin while performing rigorous resistance exercise training had smaller gains in muscle mass than the placebo group.
A Northwestern University Feinberg School of Medicine researcher has launched the first U.S. trial in which a purified form of subjects' own adult stem cells was transplanted into their leg muscles with severely blocked arteries to try to grow new small blood vessels and restore circulation in their legs.
The study, presented in a poster discussion session by Jason Fisher, a student at the University of Pittsburgh School of Engineering, analyzed data from 31 cancer patients given 30-minute infusions of gemcitabine to determine what percentage of the drug dose was associated with concentrations that exceeded the body's ability to activate the drug.
The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant formulation to be developed for respiratory distress syndrome (RDS) for premature infants in Low- and Middle-Income countries (LMIC).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Meghan Gunn, MD 140 Hospital Dr Ste 210, Bennington, VT 05201-5015 Ph: (802) 447-3930 | Dr Meghan Gunn, MD 140 Hospital Dr Ste 210, Bennington, VT 05201-5015 Ph: (802) 447-3930 |
News Archive
Proteins are the workhorses of our cells. They help to digest our food, are at the core of our immune system, and literally shape our body from top to toe. Proteins also play an important role in biotechnology in the form of enzymes, which are important in the creation of anything from pharmaceuticals to bread, washing powder and much more. Their possibilities are virtually without limit.
A clinical trial initiated by University of Kentucky researchers argues against the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass. The double-blind trial, conducted at the University of Kentucky and University of Alabama at Birmingham, found that older adults who took metformin while performing rigorous resistance exercise training had smaller gains in muscle mass than the placebo group.
A Northwestern University Feinberg School of Medicine researcher has launched the first U.S. trial in which a purified form of subjects' own adult stem cells was transplanted into their leg muscles with severely blocked arteries to try to grow new small blood vessels and restore circulation in their legs.
The study, presented in a poster discussion session by Jason Fisher, a student at the University of Pittsburgh School of Engineering, analyzed data from 31 cancer patients given 30-minute infusions of gemcitabine to determine what percentage of the drug dose was associated with concentrations that exceeded the body's ability to activate the drug.
The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant formulation to be developed for respiratory distress syndrome (RDS) for premature infants in Low- and Middle-Income countries (LMIC).
› Verified 9 days ago
Jaclyn D Lozier, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 140 Hospital Dr Ste 210, Bennington, VT 05201 Phone: 802-447-3930 Fax: 802-447-8539 | |
Martin R Luloff, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 140 Hospital Dr, Suite 207, Bennington, VT 05201 Phone: 802-447-3930 Fax: 802-447-8539 | |
Judy Kay Orton, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 901 Main St, Suite 1, Bennington, VT 05201 Phone: 802-442-6057 Fax: 802-447-1348 | |
Theodore L Johnson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 194 North Street, Bennington, VT 05201 Phone: 802-442-2264 Fax: 802-442-2337 |